Third Phase of Clinical Trials for Covaxin Starts in NIMS, HyderabadNovember 16, 2020 16:47
Third Phase of Clinical Trials for Covaxin Starts in NIMS, Hyderabad:- The coronavirus left an irreplaceable impact across the globe and several families are shattered with the losses. Several pharmaceutical companies and industries are working on a vaccine for coronavirus. They are currently in various stages of human and clinical trials. The phase three human trials of Covaxin started today in Nizams Institute of Medical Sciences, Hyderabad today morning. A team is working on the project and 600 volunteers would be given the vaccine and will be closely monitored. The first and second phases of the clinical trials are successful for Covaxin and no volunteers developed any kind of illness till date.
The Indian Council of Medical Research (ICMR) is in plans to make the vaccine available early next year if the third phase of the clinical trials are successful. Bharat Biotech in association with the Indian Council of Medical Research is developing the vaccine Covaxin. The Drugs Controller General of India is approached by Bharat Biotech on October 2nd for the vaccine for coronavirus and the permissions are granted after a meeting that was held on October 19th. The third phase of clinical trials for Covaxin are happening in 19 locations in India including Delhi, Hyderabad, Patna, Mumbai and Lucknow.